PeterAnthonyD'ArienzoMD

PubMed

• 5 citations
  Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.
  Peter A. D'Arienzo, Rudolph S Wagner, Tiffany Jamison, Belinda Bell, Joseph J. Dajcs, David W. Stroman> ;Advances in Therapy. 2010 Feb 19
• 9 citations
  Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.
  Ira Finegold, David B. Granet, Peter A. D'Arienzo, Arthur B. Epstein> ;Clinical Therapeutics. 2006 Oct 1
• 29 citations
  Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.
  Bobby Q. Lanier, Ira Finegold, Peter A. D'Arienzo, David B. Granet, Arthur B. Epstein, Greg L. Ledgerwood> ;Current Medical Research and Opinion. 2004 Aug 1
• 28 citations
  Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhi...
  Bob Q. Lanier, Mark B. Abelson, William E. Berger, David B. Granet, Peter A. D'Arienzo, Dennis L. Spangler, Martin K. Kägi> ;Clinical Therapeutics. 2002 Jul 1
• 20 citations
  Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic so...
  Peter A. D'Arienzo, Andrea Leonardi, George Bensch> ;Clinical Therapeutics. 2002 Mar 1
• Improved technique for temporary tarsorrhaphy with a new cyanoacrylate gel.
  Ehrenhaus, M., D'Arienzo, P.> ;Arch Ophthalmol. 2003 Sep
• Join now to see all